Showing results (401-410 of 525) with videos related to
Sort By:
Pageof 53
Cell Host & Microbe|August 15, 2014
HIV-1 envelope gp41 antibodies can originate from terminal ileum B cells that share cross-reactivity with commensal bacteriaAshley M Trama, M Anthony Moody, S Munir Alam, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|June 25, 2024
Safety and Immunogenicity of a DNA Vaccine With Subtype C gp120 Protein Adjuvanted With MF59 or AS01B: A Phase 1/2a HIV-1 Vaccine TrialNigel Garrett, One Dintwe, Cynthia L Monaco, et al.The Lancet. HIV|May 1, 2024
Safety and immunogenicity of a polyvalent DNA-protein HIV vaccine with matched Env immunogens delivered as a prime-boost regimen or coadministered in HIV-uninfected adults in the USA (HVTN 124): a phase 1, placebo-controlled, double-blind randomised controlled trialIan Frank, Shuying S Li, Nicole Grunenberg, et al.Journal of Virology|April 19, 2013
Mucosal immunization of lactating female rhesus monkeys with a transmitted/founder HIV-1 envelope induces strong Env-specific IgA antibody responses in breast milkGenevieve G A Fouda, Joshua D Amos, Andrew B Wilks, et al.Journal of Virology|May 4, 2012
HIV-1 gp120 vaccine induces affinity maturation in both new and persistent antibody clonal lineagesM Anthony Moody, Nicole L Yates, Joshua D Amos, et al.Plos One|August 9, 2019
Safety, pharmacokinetics, and immunogenicity of the combination of the broadly neutralizing anti-HIV-1 antibodies 3BNC117 and 10-1074 in healthy adults: A randomized, phase 1 studyYehuda Z Cohen, Allison L Butler, Katrina Millard, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 4, 2016
Boosting of ALVAC-SIV Vaccine-Primed Macaques with the CD4-SIVgp120 Fusion Protein Elicits Antibodies to V2 Associated with a Decreased Risk of SIVmac251 AcquisitionShari N Gordon, Namal P M Liyanage, Melvin N Doster, et al.Cell Reports|February 6, 2020
Neonatal Rhesus Macaques Have Distinct Immune Cell Transcriptional Profiles following HIV Envelope ImmunizationQifeng Han, Todd Bradley, Wilton B Williams, et al.Journal of Virology|January 12, 2018
HIV-1-Specific IgA Monoclonal Antibodies from an HIV-1 Vaccinee Mediate Galactosylceramide Blocking and PhagocytosisSaintedym Wills, Kwan-Ki Hwang, Pinghuang Liu, et al.NPJ Vaccines|April 16, 2021
Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humansKelly E Seaton, Aaron Deal, Xue Han, et al.Pageof 53